Abstract
This feature article provides an overview of the nascent field of pharmacoproteomics, its definitions and role in personalized medicine, and the specifications of pharmacoproteomics in developing countries. The “ideal world view” is outlined on the opportunities for pharmacoproteomics in the developing countries, for example, research in the fields of neglected tropical diseases and the potential merger of traditional holistic eastern medicine approaches and the practice of personalized medicine. An innovation analysis is performed on the distribution of pharmacoproteomics publications across the countries, and the types of publications (original research versus reviews). Pharmacoproteomics publications in the developing countries are analyzed in further detail, revealing the lower percentage of original research and higher percentage of reviews illustrating both the intention to develop pharmacoproteomics and the limitations in resources and access to the high-end proteomics instrumentation.
Keywords: Developing countries, global personalized medicine, neglected tropical diseases, omics data-intensive science, pharmacoproteomics.
Current Pharmacogenomics and Personalized Medicine
Title:Proteins Do Matter: Pharmacoproteomics Low Hanging Fruits for Global Health and Applications in Developing Countries
Volume: 10 Issue: 4
Author(s): Victor P. Andreev
Affiliation:
Keywords: Developing countries, global personalized medicine, neglected tropical diseases, omics data-intensive science, pharmacoproteomics.
Abstract: This feature article provides an overview of the nascent field of pharmacoproteomics, its definitions and role in personalized medicine, and the specifications of pharmacoproteomics in developing countries. The “ideal world view” is outlined on the opportunities for pharmacoproteomics in the developing countries, for example, research in the fields of neglected tropical diseases and the potential merger of traditional holistic eastern medicine approaches and the practice of personalized medicine. An innovation analysis is performed on the distribution of pharmacoproteomics publications across the countries, and the types of publications (original research versus reviews). Pharmacoproteomics publications in the developing countries are analyzed in further detail, revealing the lower percentage of original research and higher percentage of reviews illustrating both the intention to develop pharmacoproteomics and the limitations in resources and access to the high-end proteomics instrumentation.
Export Options
About this article
Cite this article as:
Andreev P. Victor, Proteins Do Matter: Pharmacoproteomics Low Hanging Fruits for Global Health and Applications in Developing Countries, Current Pharmacogenomics and Personalized Medicine 2012; 10 (4) . https://dx.doi.org/10.2174/187569212803901747
DOI https://dx.doi.org/10.2174/187569212803901747 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multidrug Resistance ABC Transporter Structure Predictions by Homology Modeling Approaches
Current Drug Metabolism Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Carbonic Anhydrase Inhibitors and the Management of Cancer
Current Topics in Medicinal Chemistry Cancer and Treatment Modalities
Current Cancer Therapy Reviews UBE2L6 is Involved in Cisplatin Resistance by Regulating the Transcription of ABCB6
Anti-Cancer Agents in Medicinal Chemistry Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review
Current Cancer Drug Targets Biological and Chemical Diversity of Coral-Derived Microorganisms
Current Medicinal Chemistry Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Current Neuropharmacology Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
Current Pharmaceutical Design Histone Deacetylase Inhibitors in Tumor Immunotherapy
Current Medicinal Chemistry Editorial [Peptides and Proteins in Cancer Therapy]
Protein & Peptide Letters Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells
Recent Patents on Anti-Cancer Drug Discovery Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design From TGF-β to Cancer Therapy
Current Drug Targets Role of Natural Phenolic Compounds in Cancer Chemoprevention via Regulation of the Cell Cycle
Current Pharmaceutical Biotechnology Metallopharmaceuticals in Therapy - A New Horizon for Scientific Research
Current Medicinal Chemistry Recent Patents Concerning Diagnostic and Therapeutic Applications of Aberrantly Methylated Sequences in Pancreatic Cancer
Recent Patents on DNA & Gene Sequences